Litcius/Paper detail

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui, Grégoire Rangé, Zuzana Moťovská, Jean‐Guillaume Dillinger, Ziad Boueri, Philippe Brunel, Thibault Lhermusier, Christophe Pouillot, Elisa Larrieu-Ardilouze, Franck Boccara, Jean-Noël Labeque, Paul Guedeney, Mohamad El Kasty, Mikaël Laredo, Raphaëlle Dumaine, Grégory Ducrocq, Jean‐Philippe Collet, Guillaume Cayla, Katrien Blanchart, Petr Kala, Eric Vicaut, Gilles Montalescot, Johanne Silvain, J.‐P. Collet, Gilles Montalescot, Mathieu Kernéis, Nassim Braik, Olivier Barthélémy, Gérard HELFT, C. Lefeuvre, R. Choussat, Marie Hauguel, Michel Zeitouni, Thomas Cuisset, Jean-Louis Bonnet, Pierre Deharo, Benoît Lattuca, Guillaume Cayla, Luc Cornillet, Bertrand Ledermann, Clément Lonjon, Laurent Schmutz, Grégoire Rangé, Franck Albert, Thibault Demicheli, Laurent Roussel, R. Bensaid, Christophe Thuaire, Jean-Guillaume DILLINGER, Patrick Henry, Stéphane Manzo‐Silberman, Georgios SIDERIS, Damien Logeart, Vincent Spagnoli, Léa CACOUB, Christophe Pouillot, Jean Richard VI-FANE, Jens Glasenapp, K. Bougrini, Nicolas Combaret, Pascal Motreff, Géraud Souteyrand, Aimé Amonchot, Thomas Mouyen, Thibault Lhermusier, Didier Carrié, Frédéric Bouisset, Thomas Chollet, Francisco CAMPELO-PARADA, Nicolas Delarche, François Schiele, Mathieu BESUTTI, Marie Hauguel‐Moreau, Rami EL MAHMOUD, Christophe Caussin, Mami ZOHEIR, Aurélie Veugeois, Alain Dibié, Olivier Varenne, Fabien Picard, A. Lafont, Julien Adjedj, Philippe Degrell, Farzin Beygui, Rémi Sabatier, Vincent Roule, M Bignon, Katrien Blanchart, P Ardouin, Adrien Lemaître, Clément Briet, Ziad Boueri, Pascal Goube, Pierre Coste, Laura Cetran, Jérôme Clerc, Hervé Breton, Dominique Boulmier

2020The Lancet130 citationsDOI

Topics & Concepts

TicagrelorMedicineConventional PCIPercutaneous coronary interventionClopidogrelMyocardial infarctionPopulationInternal medicineRandomized controlled trialCoronary artery diseaseLoading doseCardiologySurgeryEnvironmental healthAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchCoronary Interventions and Diagnostics
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial | Litcius